Registration & Co�ee

Welcome Speech by Leonard Sachs, Managing Director, Sachs Associates Ltd.

Public Markets and M&A Panel - Room PanoramaChaired by:Stephanie Léouzon, Partner and Head of Europe, Torreya Partners (Europe), LLPPanellists:Christian Lach, Portfolio Manager, Bellevue Asset Management AGIsabella Schidrich, Senior Managing Director, NASDAQ OMXIvo Staijen, Investment Advisor, Portfolio Manager, HBM Partners AGJames Sapirstein, CEO, ContraVir Pharmaceuticals, Inc.Mark Beards, Corporate Development Director, Cell Therapy Ltd.Thomas Stockman, Director, Healthcare Investment Banking, Royal Bank of Canada

08:00

08:30

Investment Panel - Room PanoramaCo-chaired by:Markus Goebel, Managing Director, Novartis Venture FundMarkus Hosang, General Partner and Managing Director, BioMedPartners AGPanellists:Arthur Franken, Partner, Gilde HealthcareCynthia Lavoie, General Partner, TVM Life Science Management, Inc.Lionel Carnot, Managing Director, Bay City CapitalMargarita Chavez, Director, Ventures & Early Stage Collaborations, AbbVie, Inc.Michèle Ollier, Partner, Medicxi VenturesNaveed Siddiqi, Partner, Edmond de Rothschild Investment PartnersPaul Hermant, Partner, Bird & Bird LLP

09:30

08:20

Co�ee Break10:30

Presentation Track A - Room BerneModerated by: Joergen Thorball, XOventure GmbH

DC4U B.V.09:30

Glide Pharmaceutical Technologies Limited09:40

Marinomed Biotechnologie GmbH09:50

EMTensor GmbH10:00

ATRIVA Therapeutics GmbH10:10

9th

ANNUAL

EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITIONfor Partnering and Investing in Biotech & Pharma Industry

15th -16th MARCH 2016Hilton Zurich Airport Hotel

Day One - 15th March

Oncology I – Clinical Development and Regulation in Europe - Room Panorama ACo-Chaired by:Esteban Pombo-Villar, Chief Operating O�cer, Oxford BioTherapeutics, Inc.François Thomas, President, Inserm Transfert InitiativePanellists:Eugen Leo, Senior Consultant, LEOconsultingHeinz Lubenau, General Manager and Head of Development, VAXIMM GmbHMark Vaeck, CEO, Complix N.V.Richard Godfrey, CEO, BerGenBio ASSimon Kerry, Chief Executive O�cer, Karus Therapeutics Ltd.

10:45

Oncology II - Innovation and BD&L - Room Panorama ACo-Chaired by:Esteban Pombo-Villar, Chief Operating O�cer, Oxford BioTherapeutics, Inc.Tim Herpin, Vice President, Head of Transactions (UK), AstraZenecaPanellists:Anja König, Managing Director, Novartis Venture FundDavid Malek, VP Business Development, BioLineRx Ltd.Guillaume Vignon, Director BD Oncology - Global BD and Licensing, EMD SeronoPeter Hoang, SVP BD & Strategy, Bellicum Pharmaceuticals, Inc.Jason Slingsby, Head of Business Development, Oxford BioMedica Plc

11:45

Diagnostics & Imaging Panel - Room Panorama BChaired by:Beat Merz, Managing Director, Rockport Venture PartnersPanellists:Ena Prosser, Partner, Fountain Healthcare PartnersDavid Reese, President and CEO, Provista Diagnostics, Inc. Oliver Schacht, CEO, Curetis N.V.Rainer Metzger, VP Head Precision Diagnostics and Pharma Partnering, QIAGEN GmbHThierry Chignon, Senior Partner, Merieux Developpement SASThomas Wilckens, CEO, InnVentis Ltd.

11:30

Autoimmune & Infectious Diseases Panel - Room Panorama BChaired by:Regina Hodits, General Partner, Wellington Partners Panellists:Dale Dhanoa, CEO, AKAAL Pharma Pty Ltd.Eric de La Fortelle, Venture Partner, Seventure PartnersMarkus Kalousek, Global BD&L Franchise Head, I&D, S&E, Novartis Pharma AGSimon Blake, Senior Director, Scienti�c Licensing for Immunology, J&J Pharmaceutical Research and Development

12:15Room Panorama AInterview with Laurent Audoly, SVP, Head of R&D, Managing Partner, Global Head of Drug Development and Translational Medicine, Pierre Fabre Fund for Innovationby: Adrian Dawkes, PharmaVentures Ltd.

12:30

Presentation Track C - Room BerneModerated by: Sven Rohmann, SMR Consulting GmbH

Targovax ASA - [NO:TRVX]10:45

ContraVir Pharmaceuticals, Inc. - [NASDAQ:CTRV]11:00

Addex Therapeutics Ltd. - [SIX:ADXN]11:15

Cell Therapy Ltd.11:30

Tissue Regenix Group Plc - [LON:TRX]11:45

Eos Biosciences, Inc.12:00

Presentation Track B - Room Panorama BModerated by: Hans Herklots, Capricorn One

Curetis N.V. - [EURONEXT:CURE]10:45

InnVentis Ltd.10:55

Provista Diagnostics, Inc.11:05

Inventiva Pharma12:15

ImmunID12:30

Networking Lunch13:00

9th

ANNUAL

EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITIONfor Partnering and Investing in Biotech & Pharma Industry

15th -16th MARCH 2016Hilton Zurich Airport Hotel

Space for Notes: ___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

Platform Technologies & Novel Therapeutics Panel - Room Panorama ACo-Chaired by:Chandra Leo, Partner, HBM Partners AGHeinz Schwer, CEO, Lanthio Pharma B.V.Panellists:Anker Lundemose, CEO, MISSION Therapeutics Ltd.Christophe Bonny, CSO, Bicycle Therapeutics LimitedDieter Ziegler, Director - Search and Evaluation Europe, AbbVie, Inc.Laurent Audoly, SVP, Head of R&D, Managing Partner, Global Head of Drug Development and Translational Medicine, Pierre Fabre Fund for InnovationMark Carnegie-Brown, CEO, Glide Pharmaceutical Technologies LimitedOliver Middendorp, Co-CEO & CBO, Numab AG

14:00

Innovation Panel - Room Panorama ACo-Chaired by:Matthias Bünte, Partner, Ernst & Young AGRao Movva, Novartis Distinguished Scientist, Novartis Institutes for BioMedical ResearchPanellists:Bill Blair, Director of Company Creation, Sunergos InnovationsErnst Hafen, President, BIO-TECHNOPARK Schlieren-ZurichFabian Buller, Director, New Ventures, Johnson & Johnson InnovationFrançois Thomas, President, Inserm Transfert InitiativeJoern-Peter Halle, SVP, Head of External Innovation, Biopharma, Global Research & Development, Merck KGaA Ulrich Muehlner, Global Head Outcomes Technologies Incubator (NOVAE), Novartis Pharma AG

14:45

Co�ee Break15:45

Presentation Track E - Room BerneModerated by: Hans Herklots, Capricorn One

amcure GmbH14:00

BioSight Ltd.14:10

INOFEA AG14:20

Pragma Therapeutics14:30

Therabron Therapeutics, Inc.14:40

Athera Biotechnologies AB14:50

GreenBone Ortho s.r.l.15:00

Cellestia Biotech AG15:10

MedLumics S.L.15:25

Virometix AG15:35

Presentation Track D - Room Panorama BModerated by: Bob Pooler, valuationLAB AG

OSE Pharma -[EURONEXT:OSE]14:00

BioLineRx Ltd. - [NASDAQ:BLRX]14:15

Karus Therapeutics Ltd.14:30

Avexxin AS14:45

Helsinn Healthcare SA15:00

Abzena Plc - [LON:ABZA15:15

9thEUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITIONfor Partnering and Investing in Biotech & Pharma Industry

15th -16th MARCH 2016Hilton Zurich Airport HotelANNUAL

Neuroscience Panel - Room Panorama AChaired by: Charles Bailey, Head of Search & Evaluation, Neurosciences, Novartis Pharma AGPanellists:Jennifer Laird, Senior Director, Search & Evaluation, Eli Lilly & Co.Klaus Mendla, Global Head, CNS BD and Licensing, Boehringer Ingelheim Pharma GmbH & Co. KGLaurence Barker, Dementia Discovery Fund CBO, SV Life SciencesPierandrea Muglia, VP, Head Neuroscience Discovery, UCB Pharma Tim Dyer, CEO, Addex Therapeutics Ltd.

16:00

Early Stage Investment Panel - Room Panorama AChaired by:Hakan Goker, Senior Investment Director, MS VenturesPanellists:Carina Schmidt, CEO, Athera Biotechnologies ABCaroline Goddeeris, Associate, Health & Care Team, GimvJonathan Tobin, Principal, Healthcare Ventures, Imperial InnovationsLars Gredsted, Senior Business Analyst, Wellcome TrustLuc Otten, Business Development, The Alpine Institute for Drug DiscoveryMartin P�ster, Senior Investment Manager, High-Tech-Gruenderfonds Management GmbHNanna Luneborg, Principal, Novo Ventures Reza Halse, Head of MSD European Innovation Hub, MSD

17:00

Networking Reception18:00

End of Reception & Day One20:00

Presentation Track G - Room BerneModerated by: Irene Girardello, Sachs Associates Ltd.

APIM Therapeutics AS16:00

LeukoDx Ltd.16:10

Akaal Pharma Pty Ltd.16:20

In�amalps SA16:30

Strekin AG16:40

TaiwanJ Pharmaceuticals - [TAIPEI:6549]16:50

Zytoprotec GmbH17:00

Cellply s.r.l.17:10

Presentation Track F - Room Panorama BModerated by: Subhasis Roy, Sirius Healthcare Partners

VAXIMM GmbH16:00

Oxford BioMedica Plc - [LSE:OXB]16:15

BerGenBio AS16:30

MISSION Therapeutics Ltd.16:45

Numab AG17:00

Bicycle Therapeutics Limited17:15

Canbex Therapeutics Ltd.17:30

9th EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITIONfor Partnering and Investing in Biotech & Pharma Industry

15th -16th MARCH 2016Hilton Zurich Airport HotelANNUAL

Presentation Track A - Room BerneModerated by: Joergen Thorball, XOventure GmbH

ProAxsis Ltd.09:45

Stratpharma AG09:55

Medimetrics Personalized Medicine10:05

MyoPowers Medical Technologies France SAS10:15

Genetics Microdevices Ltd.10:25

seiratherm GmbH10:35

Registration & Co�ee

Partnering Panel Session I – “How to win the big deal with pharmaceutical companies in a competitive market” - Room Panorama ACo-Chaired by:David Colpman, Director, Colpman Consulting Ltd.Nigel Borshell, VP, PharmaVentures Ltd.Panellists:Lubor Gaal, Head of Licensing and External Innovation, Almirall S.A.Martin Judge, Innovation Sourcing Director, Novo NordiskPatrick Benz, Senior Director Alliance Management, Johnson & Johnson Innovation - JJDC, Inc.Uwe Schoenbeck, SVP & Chief Scienti�c O�cer, External R&D, P�zer, Inc.

08:00

Co�ee Break10:45

09:00

Partnering Panel Session II – “The art of creative deal structures in licensing and partnering agreements” - Room Panorama ACo-Chaired by:Chris Britten, Managing Director, Torreya Partners (Europe), LLPNigel Borshell, VP, PharmaVentures Ltd.Panellists:Norbert Steinbach, Director Business Development Western Europe & Canada, AbbVie, Inc.Sarah Holland, Head of Europe, External Science and Partnering, Sano�Stewart Kay, Director Transactions, GlaxoSmithKline PlcWill Watson, Head of European Business Development, Teva Pharmaceutical Industries Ltd.

09:45

“Secure Data for Biopharmaceutical Companies” - Room Panorama A presentation by: Luisa Henk, Senior Manager Business Development, Drooms AG

10:30

9th EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITIONfor Partnering and Investing in Biotech & Pharma Industry

15th -16th MARCH 2016Hilton Zurich Airport Hotel

Day Two - 16th March

ANNUAL

Presentation Track B - Room BerneModerated by: Vincent Ossipow, Omega Funds

Provectus Biopharmaceuticals, Inc. - [NYSE:PVCT]11:00

Sophia Genetics11:15

TBA11:30

Xeltis AG11:45

Vaxart, Inc.12:00

adivo12:15

InGeneron GmbH12:30

“AM-Pharma – P�zer: A Collaboration Preparing for Success” - Room Panorama AErik van den Berg, CEO, AM-Pharma B.V.Uwe Schoenbeck, SVP & Chief Scienti�c O�cer, External R&D, P�zer, Inc.

11:00

Israel Panel - Room Panorama AChaired by:Laurent Choppe, Managing Partner, Cukierman & Co. Life SciencesPanellists:Dan Gelvan, Managing Director, Aurum Ventures M.K.I. Ltd.Ittai Harel, Managing General Partner, Pitango Venture CapitalMichal Silverberg, Senior Director, External Innovations Israel and Europe, Takeda Pharmaceuticals International GmbH Ruth Ben Yakar, CEO, BioSight Ltd.

11:15

Speech: “Top Stories and Technologies to Watch in Medtech” - Room Panorama ADavid Cassak, Managing Partner, Innovation in Medtech, LLCStephen Levin, Managing Partner, Innovation in Medtech, LLC

12:00

MedTech and Digital Health Panel - Room Panorama A Co-Chaired by:David Cassak, Managing Partner, Innovation in Medtech, LLCStephen Levin, Managing Partner, Innovation in Medtech, LLCPanellists:Bart de Witte, Healthcare Industry Leader DACH, IBMEric Rambeaux, CEO, MyoPowers Medical Technologies France SASJennifer McMahon, Associate, Seroba Life SciencesPeter Langkafel, CEO, HCB Healthcubator GmbHYves Decadt, CEO, Medimetrics Personalized Medicine

12:20

Networking Lunch13:00

Last Chance to Network15:30

End of the Forum16:00

Workshop: "How to win or avoid IP and licensing disputes. - An assessment of mistakes made by losers” - Room Panorama ANigel Borshell, VP at PharmaVentures Ltd.14:00